SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Thad L. Ocampo, Tonya S. Rans, Cannabis sativa: the unconventional “weed” allergen, Annals of Allergy, Asthma & Immunology, 2015, 114, 3, 187

    CrossRef

  2. 2
    Getaw Worku Hassen, Asha A. Roy, Ivan Becerra, Monica Diep, Ioana Scherbakova, Lara DeNonno, Roger Chirurgi, Peter McCorkell, Andrea Bulbena-Cabre, Norma Dunn, K2 types and their contents: are product disclosures true?, The American Journal of Emergency Medicine, 2015, 33, 6, 845

    CrossRef

  3. 3
    Mark E Gerich, Robert W Isfort, Bryan Brimhall, Corey A Siegel, Medical Marijuana for Digestive Disorders: High Time to Prescribe?, The American Journal of Gastroenterology, 2015, 110, 2, 208

    CrossRef

  4. 4
    Joseph J. Palamar, Lily Lee, Michael Weitzman, Prevalence and correlates of hashish use in a national sample of high school seniors in the United States, The American Journal of Drug and Alcohol Abuse, 2015, 41, 3, 197

    CrossRef

  5. 5
    David Smith, Roger Bloor, Claire George, Andriy Pysanenko, Patrik Španěl, Release of toxic ammonia and volatile organic compounds by heated cannabis and their relation to tetrahydrocannabinol content, Anal. Methods, 2015, 7, 10, 4104

    CrossRef

  6. 6
    Morris S. Odell, Matthew Y. Frei, Dimitri Gerostamoulos, Mark Chu, Dan I. Lubman, Residual cannabis levels in blood, urine and oral fluid following heavy cannabis use, Forensic Science International, 2015, 249, 173

    CrossRef

  7. You have free access to this content7
    Wayne Hall, What has research over the past two decades revealed about the adverse health effects of recreational cannabis use?, Addiction, 2015, 110, 1
  8. 8
    Kimber P. Richter, Sharon Levy, Big Marijuana — Lessons from Big Tobacco, New England Journal of Medicine, 2014, 371, 5, 399

    CrossRef

  9. You have free access to this content9
    Peter Gates, Adam Jaffe, Jan Copeland, Cannabis smoking and respiratory health: Consideration of the literature, Respirology, 2014, 19, 5
  10. 10
    Dave Stone, Cannabis, pesticides and conflicting laws: The dilemma for legalized States and implications for public health, Regulatory Toxicology and Pharmacology, 2014, 69, 3, 284

    CrossRef

  11. 11
    Peggy Pol, Nienke Liebregts, Tibor Brunt, Jan Amsterdam, Ron Graaf, Dirk J. Korf, Wim Brink, Margriet Laar, Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study, Addiction, 2014, 109, 7
  12. 12
    Ian Hamilton, Charlie Lloyd, Catherine Hewitt, Christine Godfrey, Effect of reclassification of cannabis on hospital admissions for cannabis psychosis: A time series analysis, International Journal of Drug Policy, 2014, 25, 1, 151

    CrossRef

  13. 13
    Filip M. Wiecko, William E. Thompson, Growin' Grass: Paradise by the Sodium Light, Deviant Behavior, 2014, 35, 4, 332

    CrossRef

  14. 14
    Tamara D. Warner, Dikea Roussos-Ross, Marylou Behnke, It's Not Your Mother's Marijuana, Clinics in Perinatology, 2014, 41, 4, 877

    CrossRef

  15. 15
    Tom P. Freeman, Celia J. A. Morgan, Chandni Hindocha, Gráinne Schafer, Ravi K. Das, H. Valerie Curran, Just say ‘know’: how do cannabinoid concentrations influence users' estimates of cannabis potency and the amount they roll in joints?, Addiction, 2014, 109, 10
  16. 16
    Anne Durkin, Legalization of Marijuana for Non-Medical Use: Health, Policy, Socioeconomic, and Nursing Implications, Journal of Psychosocial Nursing and Mental Health Services, 2014, 52, 9, 22

    CrossRef

  17. 17
    Fanny Pélissier, Isabelle Claudet, Anne-Laure Pélissier-Alicot, Nicolas Franchitto, Parental Cannabis Abuse and Accidental Intoxications in Children, Pediatric Emergency Care, 2014, 30, 12, 862

    CrossRef

  18. 18
    Tariq Siddiqui, Recurrent myopericarditis as a complication of Marijuana use, American Journal of Case Reports, 2014, 15, 60

    CrossRef

  19. 19
    Wayne Hall, Louisa Degenhardt, The adverse health effects of chronic cannabis use, Drug Testing and Analysis, 2014, 6, 1-2
  20. 20
    Eric L. Sevigny, Rosalie Liccardo Pacula, Paul Heaton, The effects of medical marijuana laws on potency, International Journal of Drug Policy, 2014, 25, 2, 308

    CrossRef

  21. 21
    Luca Zamengo, Giampietro Frison, Chiara Bettin, Rocco Sciarrone, Variability of cannabis potency in the Venice area (Italy): A survey over the period 2010–2012, Drug Testing and Analysis, 2014, 6, 1-2
  22. 22
    Paul Posadzki, Leala Watson, Edzard Ernst, Contamination and adulteration of herbal medicinal products (HMPs): an overview of systematic reviews, European Journal of Clinical Pharmacology, 2013, 69, 3, 295

    CrossRef

  23. 23
    Eric L. Sevigny, Is today's marijuana more potent simply because it's fresher?, Drug Testing and Analysis, 2013, 5, 1
  24. 24
    D. Mark Anderson, Benjamin Hansen, Daniel I. Rees, Medical Marijuana Laws, Traffic Fatalities, and Alcohol Consumption, Journal of Law and Economics, 2013, 56, 2, 333

    CrossRef

  25. 25
    John W. Martyny, Kate A. Serrano, Joshua W. Schaeffer, Mike V. Van Dyke, Potential Exposures Associated with Indoor Marijuana Growing Operations, Journal of Occupational and Environmental Hygiene, 2013, 10, 11, 622

    CrossRef

  26. 26
    Barbara M Moffat, Emily K Jenkins, Joy L Johnson, Weeding out the information: an ethnographic approach to exploring how young people make sense of the evidence on cannabis, Harm Reduction Journal, 2013, 10, 1, 34

    CrossRef

  27. 27
    Peter Reuter, Why Has US Drug Policy Changed So Little over 30 Years?, Crime and Justice, 2013, 42, 1, 75

    CrossRef

  28. 28
    Yukari Tsumura, Rikiya Aoki, Yoshio Tokieda, Mamoru Akutsu, Yasuharu Kawase, Tadashi Kataoka, Toshiyuki Takagi, Tomomi Mizuno, Masakatsu Fukada, Hiroshi Fujii, Kazumi Kurahashi, A survey of the potency of Japanese illicit cannabis in fiscal year 2010, Forensic Science International, 2012, 221, 1-3, 77

    CrossRef

  29. 29
    Erica N. Peters, Alan J. Budney, Kathleen M. Carroll, Clinical correlates of co-occurring cannabis and tobacco use: a systematic review, Addiction, 2012, 107, 8
  30. 30
    Jonathan T. Horey, John J. Mariani, Wendy Y. Cheng, Adam Bisaga, Maria Sullivan, Edward Nunes, Frances R. Levin, Comparison of Substance Use Milestones in Cannabis- and Cocaine-Dependent Patients, Journal of Addictive Diseases, 2012, 31, 1, 60

    CrossRef

  31. 31
    Carsten Rygaard Hjorthøj, Allan Fohlmann, Anne-Mette Larsen, Mikkel Arendt, Merete Nordentoft, Correlations and agreement between delta-9-tetrahydrocannabinol (THC) in blood plasma and timeline follow-back (TLFB)-assisted self-reported use of cannabis of patients with cannabis use disorder and psychotic illness attending the CapOpus randomized clinical trial, Addiction, 2012, 107, 6
  32. 32
    M. H. Meier, A. Caspi, A. Ambler, H. Harrington, R. Houts, R. S. E. Keefe, K. McDonald, A. Ward, R. Poulton, T. E. Moffitt, Persistent cannabis users show neuropsychological decline from childhood to midlife, Proceedings of the National Academy of Sciences, 2012, 109, 40, E2657

    CrossRef

  33. 33
    Melissa M. Norberg, Jennifer Mackenzie, Jan Copeland, Quantifying cannabis use with the Timeline Followback approach: A psychometric evaluation, Drug and Alcohol Dependence, 2012, 121, 3, 247

    CrossRef

  34. 34
    Daniel W. Bowles, Cindy L. O’Bryant, D. Ross Camidge, Antonio Jimeno, The intersection between cannabis and cancer in the United States, Critical Reviews in Oncology/Hematology, 2012, 83, 1, 1

    CrossRef

  35. 35
    BIANCA CALABRIA, WENDY SWIFT, TIM SLADE, WAYNE HALL, JAN COPELAND, The perceived health risks of cannabis use in an Australian household survey, Drug and Alcohol Review, 2012, 31, 6
  36. 36
    SUCHT, 2012, 58, 1

    CrossRef

  37. 37
    Charlotte Klein, Emily Karanges, Adena Spiro, Alexander Wong, Jarrah Spencer, Thanh Huynh, Nathan Gunasekaran, Tim Karl, Leonora E. Long, Xu-Feng Huang, Kelly Liu, Jonathon C. Arnold, Iain S. McGregor, Cannabidiol potentiates Δ9-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats, Psychopharmacology, 2011, 218, 2, 443

    CrossRef

  38. 38
    Christian D. Schubart, Iris E.C. Sommer, Willemijn A. van Gastel, Rogier L. Goetgebuer, René S. Kahn, Marco P.M. Boks, Cannabis with high cannabidiol content is associated with fewer psychotic experiences, Schizophrenia Research, 2011, 130, 1-3, 216

    CrossRef

  39. 39
    R. Maldonado, F. Berrendero, A. Ozaita, P. Robledo, Neurochemical basis of cannabis addiction, Neuroscience, 2011, 181, 1

    CrossRef

  40. 40
    Peggy Pol, Nienke Liebregts, Ron Graaf, Dirk J. Korf, Wim Brink, Margriet Laar, The Dutch Cannabis Dependence (CanDep) study on the course of frequent cannabis use and dependence: objectives, methods and sample characteristics, International Journal of Methods in Psychiatric Research, 2011, 20, 3
  41. 41
    Zlatko Mehmedic, Suman Chandra, Desmond Slade, Heather Denham, Susan Foster, Amit S. Patel, Samir A. Ross, Ikhlas A. Khan, Mahmoud A. ElSohly, Potency Trends of Δ9-THC and Other Cannabinoids in Confiscated Cannabis Preparations from 1993 to 2008, Journal of Forensic Sciences, 2010, 55, 5
  42. 42
    Shaun D. Carstairs, Michael K. Fujinaka, Grant E. Keeney, Binh T. Ly, Prolonged Coma in a Child Due to Hashish Ingestion with Quantitation of THC Metabolites in Urine, The Journal of Emergency Medicine, 2010,

    CrossRef

  43. 43
    Nora Laaris, Cameron H. Good, Carl R. Lupica, Δ9-tetrahydrocannabinol is a full agonist at CB1 receptors on GABA neuron axon terminals in the hippocampus, Neuropharmacology, 2010, 59, 1-2, 121

    CrossRef

  44. 44
    Wayne Hall, Louisa Degenhardt, Adverse health effects of non-medical cannabis use, The Lancet, 2009, 374, 9698, 1383

    CrossRef

  45. 45
    Wayne Hall, The adverse health effects of cannabis use: What are they, and what are their implications for policy?, International Journal of Drug Policy, 2009, 20, 6, 458

    CrossRef